Where do Kura Oncology's ratios come from?

Every ratio is computed from Kura Oncology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Kura Oncology KURA Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-449.9%-91.4pp	-358.5%—	——	——
Net margin	-412.9%-90.1pp	-322.9%—	——	——
Returns
Return on equity	-94.8%-51.9pp	-42.9%-5.6pp	-37.3%-8.0pp	-29.3%-6.0pp
Return on invested capital	-241.7%-175pp	-66.3%-22.6pp	-43.7%-8.9pp	-34.7%—
Efficiency
Asset turnover	0.1×0.0×	0.1×—	0×—	——
Liquidity
Current ratio	6.1×-3.4×	9.5×-2.8×	12.3×-6.3×	18.6×-4.7×
Leverage
Debt-to-equity	0.1×+0.1×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$1.99-58.6%	$4.80-11.5%	$5.43-13.5%	$6.27-17.8%
Valuation
Market capitalization	$942.78M+86.2%	$677.32M-39.1%	$1.11B+32.2%	$841.16M-9.8%
Price / sales	13.2×+3.9×	12.6×—	——	——
Price / book	8.7×+7.3×	1.6×-1.2×	2.8×+0.8×	2×+0.2×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Kura Oncology.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Kura Oncology's ratios come from?: Every ratio is computed from Kura Oncology's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.